FOX NEWS - A Georgia woman who is three years into a painful recovery is suing after claiming she received the wrong dosage of a medication that caused her body to burn from the inside out. Khaliah Shaw, 26, spent three weeks in a medically induced coma while her skin slowly peeled off and wants to ensure that other patients are protected from pharmaceutical errors, 11Alive.com reported.
“This did not have to happen,” Shaw, who lives in Snellville, about 30 miles northeast of Atlanta, told 11Alive.com. “This was not just some sort of fluke in my opinion. This happened as a directly (sic) result of somebody’s error.”
In 2014, Shaw told her doctors she felt depressed and received a prescription for Lamictal, an anti-seizure medication sometimes used to treat bipolar disorders, the Tech Times reported. The prescription drug also is sometimes used to treat bipolar disorder.
Shaw took the medication for two weeks before she started breaking out in blisters. Shaw told the news outlet that her body felt like it “was on fire.”
Eventually, doctors diagnosed her with Stevens Johnson Syndrome, a rare skin disorder that is typically caused by an adverse reaction to medication, 11Alive.com reported.
“It essentially causes your body to burn from the inside out, and you pretty much just melt,” she told 11Alive.com.
The Palm Beach Post reported that others are also suing pharmaceutical company GlaxoSmithKline (GSK) for promoting Lamictal without advertising its risks in full. In July 2012, the pharmaceutical company pleaded guilty to criminal negligent charges for allegations of fraud and failure to report product safety data for the drug, the newspaper reported. GSK paid $3 billion total.
As for Shaw, the young woman has come to resemble a burn victim. She has lost her fingernails and sweat glands, and she is slowly going blind, 11Alive.com reported.
“They’re telling me this could happen again, and they’re telling me if it did happen again, that it would be worse,” Shaw told the news outlet.
The lawsuit claims her medical bills total upwards of $3.45 million and are expected to continue to grow as she continues receiving treatment.